Rapid Diagnostics - warts and all - BSMT 39th Annual Microbiology Conference.

TOPICS COVERED

A day spent looking at the advantages and disadvantages of rapid diagnostics and how the value is assessed in routine clinical pathways. Also, an opportunity to listen to leading experts an Antimicrobial Resistance (AMR), looking at STI surveillance from a molecular approach and an update on The AMR National Action plan 2024-2029. Also, an insight into setting a lab up from scratch in a third world country with limited resource. There will be a chance to interact with commercial companies and see the latest technology available on the market.

• Improvement in knowledge of the value of Rapid Diagnostics from key opinion leaders
• Improvement in knowledge of antimicrobial resistance and recent advances in strategic future plans
• Information on the development of new technologies and advances in molecular testing methods to detect infections and how it may be utilised in the microbiology laboratory.
• The chance to partake in ‘live’ question and answers sessions after each session.

WHO SHOULD ATTEND?

BSMT conferences are aimed at senior biomedical and clinical scientists, other scientists, medical microbiologists and other healthcare professionals. They are particularly relevant for bench microbiologists to provide up-to-date information about organisms and techniques especially with regard to new molecular technologies.

SPEAKERS

Key Note speakers include:

• Dr Luke Moore, Consultant Infectious Diseases, Microbiology, & Virology, Chelsea & Westminster NHS Foundation Trust - How do we assess and value rapid diagnostics?
• Dr Jesus Rodriguez-Manzano, Associate Professor, Imperial College, London - Next-generation molecular diagnostics: Leveraging digital technologies to enhance multiplexing in real-time PCR
• Dr Michelle Cole, Interim Head of the STI Reference lab, UKHSA - STI AMR surveillance; the molecular approach
• Ivor Mitchelmore, Now retired Chief BMS, Luton - Setting up a Microbiology service in a low to middle income.
• Adela Alcolea-Medina, Lead, Next Generation Sequencing, Infection Sciences, Synovis, St Thomas’ Hospital, London -Evaluation of a unified metagenomic method for rapid detection of bacteria, fungi and viruses in clinical samples
• Dr Alicia Demirjian, Clinical Lead, Antimicrobial Resistance & Prescribing (AMRP), UKHSA, and Consultant in Paediatric Infectious Diseases and Immunology, Evelina London Children’s Hospital - UKHSA: What next for AMR? The 2024-2029 UK Antimicrobial Resistance National Action Plan

Chairs:

• Dr Kate Templeton, President of the BSMT
• Professor Brian Duerden CBE

For more information, please contact: [email protected]